SC Filed 2018-03-20 Event — SEC 0000919574-18-002589 →

Broadfin Capital, LLC → NOVELION THERAPEUTICS INC.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on NOVELION THERAPEUTICS INC.

Filed	Form	Filer	Stake	Shares
2019-06-20	SC	Whitefort Capital Master Fund, LP	—	—	view →
2019-04-02	SC	Whitefort Capital Master Fund, LP	—	—	view →
2018-07-16	SC	EdgePoint Investment Group Inc.	—	—	view →
2018-03-19	SC	Sarissa Capital Management LP	—	—	view →

Other Filings by Broadfin Capital, LLC

Filed	Form	Issuer	Stake	Shares
2020-06-23	SC	STRATA Skin Sciences, Inc. SSKN	—	—	view →
2020-01-23	SC	STRATA Skin Sciences, Inc. SSKN	—	—	view →
2020-01-22	SC	STRATA Skin Sciences, Inc. SSKN	—	—	view →
2019-12-23	SC	BIODELIVERY SCIENCES INTERNATIONAL INC	—	—	view →
2019-10-04	SC	AVADEL PHARMACEUTICALS PLC	—	—	view →
2018-05-01	SC	BIODELIVERY SCIENCES INTERNATIONAL INC	—	—	view →
2018-03-15	SC	Recro Pharma, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →